Greetings

home - Greetings
Welcome to the Korean Society of Diagnostic Genetics (KSGD), a leader in professionalism, diversity, and inclusion in the field of clinical genomics/diagnostic genetics!

Our society started as a research society in 2006 and has grown into a full-fledged society since 2011. Currently, it has grown into an society with 2,500 members thanks to the participation of experts in the field of clinical genomics/diagnostic genetics.

Our society holds regular academic conferences every year to provide a venue for exchanging the latest academic information in the field of genetics, and operates various separate educational programs that can be applied to clinical testing environments, such as the Cytogenetics Workshop, Next Generation Sequencing (NGS) Workshop, Bioinformatics Workshop, Molecular Microbiology Mini-Workshop, Genetic Counseling Training Course, and Korea Institute of Genetic Testing Evaluation Examiner Training.

Since 2017, we have been providing a venue for in-depth discussion and debate on related issues through the ELSI Symposium, the only one in Korea to address ethical, legal, and social issues related to genetic testing, and from 2023, we will operate a program with enhanced content related to rare diseases. As a result of these continuous efforts, our society was designated as a genetic testing education institution by the Ministry of Health and Welfare in 2024.

Through the annual clinical guideline contest, we have been striving to develop and utilize guidelines that fit the topics our members need, such as liquid biopsy, NGS testing for blood tumors, testing methods by molecular genetic testing technique, recommendations for explanation of genetic testing results for various diseases, formats for results reports, and clinical guidelines for chromosome microarray testing. Based on these efforts, we are developing the capacity to proactively respond to major issues such as the revision of the Bioethics and Safety Act, introduction of DTC genetic testing, and introduction of whole genome sequencing.

Our society, which leads precision medicine, will establish itself as a leading player in the upcoming era of genome sequencing. As the president of the Korean Society of Diagnostic Genetics, I will do my best to strengthen the status of the society and the professional capabilities of the society members in a rapidly changing environment together with the newly formed 2025 executive members.

I would like to express my infinite respect and gratitude to the former presidents, executive members, and all members who have worked hard for the development of the society, and I ask for your active participation and interest in the activities of the society.

Thank you.

The President of the Korean Society for Genetic Diagnostics Myung-Hyun Nam​

TOP